SCHEMBL1703685

SCHEMBL1703685

CCCCCCCCCCCCCC[PH](c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
DNM1 Q05193 2/20 0.40
EPHX2 P34913 2/20 0.40
TP53 P04637 1/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PKM P14618 1/20 0.39
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
CETP P11597 3/20 0.39
MMP2 P08253 1/20 0.39
MMP3 P08254 1/20 0.39
MMP9 P14780 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL160393 1.00 MEN1 (0.42) MEN1KMT2ADNM1EPHX2TP53
SCHEMBL4386268 1.00 MEN1 (0.42) MEN1KMT2ADNM1EPHX2TP53
SCHEMBL5301933 1.00 MEN1 (0.42) MEN1KMT2ADNM1EPHX2TP53
SCHEMBL9165455 1.00 MEN1 (0.42) MEN1KMT2ADNM1EPHX2TP53
SCHEMBL837479 1.00 MEN1 (0.42) MEN1KMT2ADNM1EPHX2TP53
SCHEMBL4650965 1.00 MEN1 (0.42) MEN1KMT2ADNM1EPHX2TP53
SCHEMBL427955 1.00 MEN1 (0.42) MEN1KMT2ADNM1EPHX2TP53
SCHEMBL868174 1.00 MEN1 (0.42) MEN1KMT2ADNM1EPHX2TP53
SCHEMBL3149218 1.00 MEN1 (0.42) MEN1KMT2ADNM1EPHX2TP53
SCHEMBL5302396 1.00 MEN1 (0.42) MEN1KMT2ADNM1EPHX2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250034184-A1 QUATERNARY PHOSPHONIUM COMPOUNDS AND USES THEREOF EMORY UNIVERSITY (US) 2025-01-30 US claimed
EP-4387628-A1 QUATERNARY PHOSPHONIUM COMPOUNDS AND USES THEREOF Emory University (US) 2024-06-26 EP claimed
WO-2023023113-A1 QUATERNARY PHOSPHONIUM COMPOUNDS AND USES THEREOF EMORY UNIVERSITY (US) 2023-02-23 WO claimed
CN-110028672-B Comb-shaped polythioether compound containing sulfur, nitrogen and oxygen atoms, and synthetic method and application thereof 烟台大学 2021-09-17 CN claimed
CN-110028672-A A kind of sulfur-bearing, nitrogen, oxygen atom comb shape polysulfide ether compound and its preparation method and use 烟台大学 2019-07-19 CN claimed
EP-2563375-B1 PHARMACEUTICAL COMPOSITIONS WITH PHOSPHONIUM ANTIMICROBIAL AGENTS ALCON RES LTD (US) 2014-06-25 EP claimed
EP-1196523-B1 CLEANSING COMPOSITION COMPRISING A WATER SOLUBLE OR WATER DISPERSIBLE POLYMER RHODIA CHIMIE SA (FR) 2004-09-15 EP claimed
EP-1196523-A1 CLEANSING COMPOSITION COMPRISING A WATER SOLUBLE OR WATER DISPERSIBLE POLYMER Rhodia Chimie (FR) 2002-04-17 EP claimed
WO-2001005920-A1 CLEANSING COMPOSITION COMPRISING A WATER SOLUBLE OR WATER DISPERSIBLE POLYMER RHODIA CHIMIE (FR) 2001-01-25 WO claimed
EP-1022941-A1 SYSTEM BASED ON A BIOCIDE AND A POLYETHER SILICON FOR DISINFECTING HARD SURFACES RHODIA CHIMIE (FR) 2000-08-02 EP claimed
WO-1999018784-A1 SYSTEM BASED ON A BIOCIDE AND A POLYETHER SILICON FOR DISINFECTING HARD SURFACES RHODIA CHIMIE (FR) 1999-04-22 WO claimed
EP-0724562-B1 SYNTHESIS OF SPHINGOSINES VIRGINIA TECH INTELL PROP (US) 1998-06-03 EP claimed
EP-0213547-B1 CYCLOHEXANEALKANOIC ACIDS MERRELL DOW PHARMACEUTICALS INC. (US) 1990-12-27 EP claimed
WO-2025057858-A1 RESIST MATERIAL AND METHOD FOR PRODUCING SAME 東京応化工業株式会社 2025-03-20 WO disclosed
WO-2025057857-A1 SOLVATE OF POLYACID SALT AND METHOD FOR PRODUCING SAME 東京応化工業株式会社 2025-03-20 WO disclosed
US-20250034184-A1 QUATERNARY PHOSPHONIUM COMPOUNDS AND USES THEREOF EMORY UNIVERSITY (US) 2025-01-30 US disclosed
CN-1033630-A bicyclic peroxide and preparation method thereof HOFFMANN LA ROCHE (CH) 1989-07-05 CN disclosed
EP-0170619-B1 BIOCIDAL COMPOSITION CIBA-GEIGY AG (CH) 1989-06-21 EP disclosed
EP-0311955-A2 Bicyclic peroxide F. HOFFMANN-LA ROCHE AG (CH) 1989-04-19 EP disclosed
EP-0170619-A1 Biocidal composition CIBA-GEIGY AG (CH) 1986-02-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250034184-A1 QUATERNARY PHOSPHONIUM COMPOUNDS AND USES THEREOF CD47, BTK, PHOSPHO1 MEN1 809/4885KMT2A 711/4885DNM1 1866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.